There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (1)

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes.


Actions Overview (1)

Date Actions Overview
06/24/2019Introduced in House

All Actions (4)

Date All Actions
07/24/2019Sponsor introductory remarks on measure. (CR E971)
Action By: House of Representatives
06/25/2019Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
06/24/2019Referred to the House Committee on Energy and Commerce.
Action By: House of Representatives
06/24/2019Introduced in House
Action By: House of Representatives

Cosponsors (3)

* = Original cosponsor
CosponsorDate Cosponsored
Rep. Latta, Robert E. [R-OH-5]* 06/24/2019
Rep. Dingell, Debbie [D-MI-12]* 06/24/2019
Rep. Guthrie, Brett [R-KY-2]* 06/24/2019

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce06/24/2019 Referred to
House Energy and Commerce Subcommittee on Health06/25/2019 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.


Latest Summary (0)

A summary is in progress.